Table of Contents Author Guidelines Submit a Manuscript
Surgery Research and Practice
Volume 2014, Article ID 801643, 6 pages
http://dx.doi.org/10.1155/2014/801643
Research Article

Flow Cytometric Evaluation of T Cell Activation Markers after Cardiopulmonary Bypass

1University Hospital Leipzig, Heart Center, Department of Cardiac Surgery, 04289 Leipzig, Germany
2Florida Hospital Orlando, Department of Cadiothoracic Transplantation and Advanced Cardiac Surgery, Orlando, FL 32803, USA
3University Hospital Leipzig, Heart Center, Department of Pediatric Cardiology, 04289 Leipzig, Germany

Received 4 November 2013; Accepted 25 December 2013; Published 6 February 2014

Academic Editor: Thomas Strecker

Copyright © 2014 Maja-Theresa Dieterlen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Bocsi, M. Richter, J. Hambsch et al., “Transient Th1/Th2 disbalance indicates postoperative effusions and edema after cardiopulmonary bypass in children,” Cytometry A, vol. 69, no. 3, pp. 165–168, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. R. I. Hall, M. S. Smith, and G. Rocker, “The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacological considerations,” Anesthesia and Analgesia, vol. 85, no. 4, pp. 766–782, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. C. S. Rinder, J. P. Mathew, H. M. Rinder, J. B. Tracey, E. Davis, and B. R. Smith, “Lymphocyte and monocyte subset changes during cardiopulmonary bypass: effects of aging and gender,” Journal of Laboratory and Clinical Medicine, vol. 129, no. 6, pp. 592–602, 1997. View at Google Scholar · View at Scopus
  4. C. S. Ng and S. Wan, “Limiting inflammatory response to cardiopulmonary bypass: pharmaceutical strategies,” Current Opinion in Pharmacology, vol. 12, no. 2, pp. 155–159, 2012. View at Google Scholar
  5. P. Hornick and K. M. Taylor, “Immune and inflammatory responses after cardiopulmonary bypass,” in Cardiopulmonary Bypass: Principles and Practices, G. P. Gravlee, R. F. Davis, M. Kurusz, and J. R. Utley, Eds., chapter 15, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2nd edition, 2008. View at Google Scholar
  6. J. I. Brody, N. J. Pickering, G. B. Fink, and E. D. Behr, “Altered lymphocyte subsets during cardiopulmonary bypass,” The American Journal of Clinical Pathology, vol. 87, no. 5, pp. 626–628, 1987. View at Google Scholar · View at Scopus
  7. H. van Velzen-Blad, Y. J. Dijkstra, C. J. Heijnen, G. A. Schurink, B. J. Zegers, and R. E. Ballieux, “Cardiopulmonary bypass and host defense functions in human beings: II. Lymphocyte function,” Annals of Thoracic Surgery, vol. 39, no. 3, pp. 212–217, 1985. View at Google Scholar · View at Scopus
  8. A. Naldini, E. Borrelli, S. Cesari, P. Giomarelli, and M. Toscano, “In vitro cytokine production and T-cell proliferation in patients undergoing cardiopulmonary by-pass,” Cytokine, vol. 7, no. 2, pp. 165–170, 1995. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Franke, W. Lante, E. Kurig, L. G. Zöller, C. Weinhold, and A. Markewitz, “Hyporesponsiveness of T cell subsets after cardiac surgery: a product of altered cell function or merely a result of absolute cell count changes in peripheral blood?” European Journal of Cardio-Thoracic Surgery, vol. 30, no. 1, pp. 64–71, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Lante, A. Franke, C. Weinhold, and A. Markewitz, “Immunoglobulin levels and lymphocyte subsets following cardiac operations: further evidence for a T-helper cell shifting,” Thoracic and Cardiovascular Surgeon, vol. 53, no. 1, pp. 16–22, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. M. J. Barten, A. Tarnok, J. Garbade et al., “Pharmacodynamics of T-cell function for monitoring immunosuppression,” Cell Proliferation, vol. 40, no. 1, pp. 50–63, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. M. J. Barten, S. Dhein, H. Chang et al., “Assessment of immunosuppressive drug interactions: inhibition of lymphocyte function in peripheral human blood,” Journal of Immunological Methods, vol. 283, no. 1-2, pp. 99–114, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. M. J. Barten, J. F. Gummert, T. van Gelder, R. Shorthouse, and R. E. Morris, “Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood: inhibition by immunosuppressive drugs in vitro,” Journal of Immunological Methods, vol. 253, no. 1-2, pp. 95–112, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Wang, Y. Liu, R. Han et al., “Monitoring of CD95 and CD38 expression in peripheral blood T lymphocytes during active human cytomegalovirus infection after orthotopic liver transplantation,” Journal of Gastroenterology and Hepatology, vol. 25, no. 1, pp. 138–142, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. M. J. Barten, A. Rahmel, J. Garbade et al., “Pharmacodynamic monitoring of the conversion of cyclosporine to tacrolimus in heart and lung transplant recipients,” Transplantation Proceedings, vol. 37, no. 10, pp. 4532–4534, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Berry, A. Magill, M. Yost, J. Janosky, and R. Sindhi, “Individualizing combination of two antiproliferative immunosuppressants with pharmacodynamic modeling of stimulated lymphocyte responses,” Cytometry A, vol. 69, no. 2, pp. 95–103, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Al-Ruzzeh, G. Hoare, N. Marczin et al., “Off-pump coronary artery bypass surgery is associated with reduced neutrophil activation as measured by the expression of CD11b: a prospective randomized study,” Heart Surgery Forum, vol. 6, no. 2, pp. 89–93, 2003. View at Google Scholar · View at Scopus
  18. P. F. Halloran, “Immunosuppressive drugs for kidney transplantation,” The New England Journal of Medicine, vol. 351, no. 26, pp. 2715–2729, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. C. H. Yeh, B. C. Cheng, C. C. Hsu et al., “Induced interleukin-19 contributes to cell-mediated immunosuppression in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass,” Annals of Thoracic Surgery, vol. 92, no. 4, pp. 1252–1259, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. Z. Q. Chu and Q. Ji, “Sirolimus did not affect CD4+CD25high forkhead box p3+T cells of peripheral blood in renal transplant recipients,” Transplantation Proceedings, vol. 45, no. 1, pp. 153–156, 2013. View at Publisher · View at Google Scholar
  21. T. Zhao, C. Yang, Y. Qiu et al., “Comparison of regulatory T cells and FoxP3-positive T cell subsets in the peripheral blood of renal transplant recipients with sirolimus versus cyclosporine: a preliminary study,” Transplantation Proceedings, vol. 45, no. 1, pp. 148–152, 2013. View at Google Scholar